Non-haematological cancer morphology codes excluding skin basal cell and squamous cancers
Codelist metadata
-
Coding system
- SNOMED CT
-
Coding system release
- unknown
-
Organisation
- NHSD Primary Care Domain Refsets
-
Codelist ID
- nhsd-primary-care-domain-refsets/nhaemcanmorph_cod
-
Version Tag
- 20211221
-
Version ID
- 71fe825b
Versions
About
Description
Taken from the NHAEMCANMORPH_COD refset published by NHSD.
References
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
Codes not in the full codelist are in faint grey.
Morphologic Abnormality
Intraductal papillary-mucinous carcinoma, non-invasive(
128691004)Malignant neoplasm of primary, secondary, or uncertain origin(
367651003)├Kaposi's sarcoma - category(
372147008)├Malignant epithelial neoplasm - category(
399879007)│├Carcinoma with osteoclast-like giant cells(
128631001)│├Carcinoma, anaplastic(
58248003)│├Carcinoma, metastatic(
79282002)││├Metastatic renal cell carcinoma(
838281000)││└Metastatic small cell carcinoma(
709194001)│├Carcinoma, no subtype(
68453008)│├Carcinoma, undifferentiated(
38549000)│├Carcinomatosis(
7010000)│├Combined small cell carcinoma(
21326004)│├Epithelial-myoepithelial carcinoma(
9618003)│├Epithelioma, malignant(
71298006)│├Giant cell and spindle cell carcinoma(
72969003)│├Glassy cell carcinoma(
128630000)│├Hepatoid adenocarcinoma(
128706007)│├Infiltrating duct carcinoma(
82711006)│├Large cell carcinoma(
22687000)│├Large cell carcinoma with rhabdoid phenotype(
128629005)│├Malignant adenomatous neoplasm - category(
399961007)││├Adenocarcinoma, metastatic(
4590003)││├Malignant endometrioid tumor(
253014007)││├Papillary adenocarcinoma, metastatic(
708939001)││└Primary malignant adenomatous neoplasm(
450594004)││ ├Acidophil carcinoma(
51217003)││ ├Adenocarcinoid tumor(
86293007)││ ├Adenocarcinoma in adenomatous polyp(
43233001)││ ├Adenocarcinoma in adenomatous polyposis coli(
57513006)││ ├Adenocarcinoma in multiple adenomatous polyps(
47299001)││ ├Adenocarcinoma in tubulovillous adenoma(
5658009)││ ├Adenocarcinoma in villous adenoma(
36087009)││ ├Adenocarcinoma of anal glands(
128655006)││ ├Adenocarcinoma with apocrine metaplasia(
22694002)││ ├Adenocarcinoma with cartilaginous and osseous metaplasia(
56484001)││ ├Adenocarcinoma with metaplasia(
253026002)││ ├Adenocarcinoma with mixed subtypes(
128662002)││ ├Adenocarcinoma with neuroendocrine differentiation(
128704005)││ ├Adenocarcinoma with spindle cell metaplasia(
68358000)││ ├Adenocarcinoma with squamous metaplasia(
15176003)││ ├Adenocarcinoma, endocervical type(
128682003)││ ├Adenocarcinoma, intestinal type(
25190001)││ ├Adenocarcinoma, no subtype(
35917007)││ ├Adenosquamous carcinoma(
59367005)││ ├Adrenal cortical carcinoma(
2227007)││ ├Alveolar adenocarcinoma(
36310008)││ ├Apocrine adenocarcinoma(
57141000)││ ├Basal cell adenocarcinoma(
34603009)││ ├Basophil carcinoma(
47107000)││ ├Bile duct cystadenocarcinoma(
50422007)││ ├Bronchiolo-alveolar adenocarcinoma(
112677002)││ ├Bronchiolo-alveolar carcinoma, mixed mucinous and non-mucinous(
128661009)││ ├Bronchiolo-alveolar carcinoma, mucinous(
128660005)││ ├Bronchiolo-alveolar carcinoma, non-mucinous(
128659000)││ ├Carcinoma of salivary gland type(
384951004)││ │├Adenoid cystic carcinoma(
11671000)││ │├Malignant myoepithelioma(
128884000)││ │└Mucoepidermoid carcinoma(
4079000)││ │ ├Intraosseous mucoepidermoid carcinoma(
699229009)││ │ ├Mucoepidermoid carcinoma, high grade(
397081004)││ │ ├Mucoepidermoid carcinoma, intermediate grade(
397080003)││ │ ├Mucoepidermoid carcinoma, low grade(
397079001)││ │ ├Mucoepidermoid eccrine carcinoma(
400180002)││ │ └Sclerosing mucoepidermoid carcinoma with eosinophilia(
822964002)││ ├Carcinoma simplex(
45881000)││ ├Carcinoma, diffuse type(
24505004)││ ├Ceruminous adenocarcinoma(
58069009)││ ├Cholangiocarcinoma(
70179006)││ ├Chromophobe carcinoma(
1443001)││ ├Clear cell adenocarcinofibroma(
128891002)││ ├Clear cell adenocarcinoma(
30546008)││ ├Collecting duct carcinoma(
128669006)││ ├Combined hepatocellular carcinoma and cholangiocarcinoma(
52178006)││ ├Composite carcinoid(
51465000)││ ├Cribriform carcinoma(
30156004)││ ├Cribriform comedo-type adenocarcinoma(
733838009)││ ├Cyst-associated renal cell carcinoma(
128666004)││ ├Cystadenocarcinoma(
21008007)││ ├Endometrioid adenocarcinoma, ciliated cell variant(
128681005)││ ├Endometrioid adenocarcinoma, secretory variant(
128680006)││ ├Endometrioid adenofibroma, malignant(
18105004)││ ├Endometrioid carcinoma(
30289006)││ ├Fetal adenocarcinoma(
128893004)││ ├Follicular adenocarcinoma(
5257006)││ ├Follicular adenocarcinoma, trabecular(
72174007)││ ├Follicular adenocarcinoma, well differentiated(
28173006)││ ├Follicular carcinoma, minimally invasive(
128671006)││ ├Gastrinoma, malignant(
19756007)││ ├Glucagonoma, malignant(
66515009)││ ├Glycogen-rich carcinoma(
74280008)││ ├Granular cell carcinoma(
69028005)││ ├Hepatocellular carcinoma(
25370001)││ ├Hepatocellular carcinoma, clear cell type(
128649001)││ ├Hepatocellular carcinoma, pleomorphic type(
128650001)││ ├Hepatocellular carcinoma, scirrhous(
128646008)││ ├Hepatocellular carcinoma, spindle cell variant(
128648009)││ ├Insular carcinoma(
128673009)││ ├Insulinoma, malignant(
20955008)││ ├Klatskin's tumor(
6492006)││ ├Linitis plastica(
37995004)││ ├Lipid-rich carcinoma(
3839000)││ ├Medullary carcinoma with amyloid stroma(
128916007)││ ├Meibomian adenocarcinoma(
103692002)││ ├Micropapillary adenocarcinoma(
733878002)││ ├Micropapillary carcinoma(
450895005)││ ├Mixed acidophil-basophil carcinoma(
23444003)││ ├Mixed cell adenocarcinoma(
38958001)││ ├Mixed islet cell and exocrine adenocarcinoma(
999000)││ ├Mixed medullary-follicular carcinoma(
128678000)││ ├Mixed medullary-papillary carcinoma(
128679008)││ ├Mucinous adenocarcinofibroma(
128888002)││ ├Mucinous adenocarcinoma(
72495009)││ ├Mucinous minimally invasive adenocarcinoma(
733884004)││ ├Mucinous tubular and spindle cell carcinoma(
734077004)││ ├Multilocular cystic renal cell neoplasm of low malignant potential(
734036003)││ ├Non-intestinal type adenocarcinoma(
732977002)││ ├Non-mucinous minimally invasive adenocarcinoma(
733885003)││ ├Oxyphilic adenocarcinoma(
57596004)││ ├Pancreatobiliary-type carcinoma(
450894009)││ ├Papillary adenocarcinoma(
4797003)││ ├Papillary carcinoma, columnar cell(
128677005)││ ├Papillary carcinoma, follicular variant(
21968007)││ ├Papillary carcinoma, oxyphilic cell(
128675002)││ ├Papillary microcarcinoma(
128674003)││ ├Parietal cell carcinoma(
128654005)││ ├Pituitary carcinoma(
128665000)││ ├Renal cell carcinoma(
41607009)││ ├Renal cell carcinoma, chromophobe cell(
128667008)││ ├Renal cell carcinoma, sarcomatoid(
128668003)││ ├Scirrhous adenocarcinoma(
4584002)││ ├Sebaceous adenocarcinoma(
54734006)││ ├Sebaceous lymphadenocarcinoma(
734055003)││ ├Serous adenocarcinofibroma(
128886003)││ ├Serrated adenocarcinoma(
450948005)││ ├Solid carcinoma(
81920005)││ ├Somatostatinoma, malignant(
128643000)││ ├Superficial spreading adenocarcinoma(
81446001)││ ├Sweat gland adenocarcinoma(
32272007)││ │└Endocrine mucin-producing sweat gland carcinoma(
822967009)││ ├Thymic carcinoma with adenoid cystic carcinoma-like features(
725504002)││ ├Trabecular adenocarcinoma(
29792007)││ ├Tubular adenocarcinoma(
4631006)││ ├Villous adenocarcinoma(
28558000)││ ├Vipoma, malignant(
31131002)││ └Water-clear cell adenocarcinoma(
80727009)│├Malignant basal cell tumor(
252995000)││├Basal cell adenocarcinoma(
34603009)││├Basal cell carcinoma - category(
400137006)│││├Adenoid basal carcinoma(
128637002)│││├Basal cell carcinoma(
1338007)│││├Basal cell carcinoma, fibroepithelial(
43369006)│││├Basal cell carcinoma, nodular(
128636006)│││├Basosquamous carcinoma(
37304002)│││├Infiltrating basal cell carcinoma(
56665009)│││└Multifocal superficial basal cell carcinoma(
61098004)││├Metatypical carcinoma(
6641007)││├Pilomatrix carcinoma(
24762001)││└Trichilemmocarcinoma(
128624000)│├Malignant squamous tumor, primary(
252988009)││├Adenoid squamous cell carcinoma(
85956000)││├Basaloid squamous cell carcinoma(
128634009)││├Lymphoepithelial carcinoma(
7300000)││├Papillary carcinoma(
25910003)││├Papillary squamous cell carcinoma(
39056008)││├Pseudovascular squamous cell carcinoma(
733897002)││├Squamous cell carcinoma with horn formation(
128633003)││├Squamous cell carcinoma, clear cell type(
128635005)││├Squamous cell carcinoma, keratinizing(
18048008)││├Squamous cell carcinoma, large cell, nonkeratinizing(
45490001)││├Squamous cell carcinoma, microinvasive(
12478003)││├Squamous cell carcinoma, no International Classification of Diseases for Oncology subtype(
28899001)│││├Human papillomavirus negative squamous cell carcinoma(
783213006)│││├Human papillomavirus positive squamous cell carcinoma(
783212001)│││├Metaplastic squamous cell carcinoma(
399739006)│││└Squamous cell carcinoma in post-traumatic skin lesion(
399494004)││├Squamous cell carcinoma, small cell, nonkeratinizing(
35718007)││├Squamous cell carcinoma, spindle cell(
10288008)││└Verrucous carcinoma(
89906000)│├Metaplastic carcinoma(
128705006)││├Fibromatosis-like metaplastic carcinoma(
733875004)││└Metaplastic squamous cell carcinoma(
399739006)│├Non-small cell carcinoma(
128632008)│├Nuclear protein in testis associated carcinoma(
733922002)│├Odontogenic ghost cell carcinoma(
788580003)│├Pleomorphic carcinoma(
16741004)│├Polygonal cell carcinoma(
70401000)│├Poorly differentiated carcinoma(
703078002)│├Pseudosarcomatous carcinoma(
23109009)│├Small cell carcinoma(
74364000)│├Small cell carcinoma, fusiform cell(
74042001)│├Small cell carcinoma, intermediate cell(
5958006)│└Spindle cell carcinoma(
65692009)├Malignant fibromatous neoplasm(
400163001)├Malignant germ cell neoplasm(
713582000)│├Choriocarcinoma, no International Classification of Diseases for Oncology subtype(
44769000)│├Diffuse embryoma(
399560003)│├Dysgerminoma(
60718004)│├Embryonal carcinoma(
28047004)│├Endodermal sinus tumor(
74409009)│├Germ cell neoplasm with hematological malignancy(
734070002)│├Germ cell neoplasm with somatic-type solid malignancy(
734071003)│├Germ cell tumor, nonseminomatous(
128766005)│├Germinoma(
28307001)│├Intratubular malignant germ cells(
128902002)│├Malignant teratoma - category(
416062005)││├Malignant immature teratoma(
827161000)││├Malignant teratoma, intermediate(
21912003)││├Malignant teratoma, undifferentiated(
83292005)││├Postpubertal type teratoma(
733890000)││├Prepubertal type mixed teratoma and yolk sac neoplasm(
733918007)││├Teratocarcinoma(
67830002)││├Teratoma with malignant transformation(
88334008)││└Teratoma, malignant, no International Classification of Diseases for Oncology subtype(
19467007)│├Mixed germ cell tumor(
32844007)│├Polyembryoma(
28325008)│├Regressed germ cell tumor(
399523002)│├Seminoma - category(
443677002)│├Seminoma, anaplastic(
72907003)│├Spermatocytic seminoma(
9294008)│└Struma ovarii, malignant(
18854008)├Malignant hemangioma(
253052008)├Malignant hematopoietic neoplasm(
414644002)├Malignant lipomatous tumor morphology(
253044005)├Malignant melanoma - category(
372156000)│├Acral lentiginous melanoma, malignant(
16974005)│├Amelanotic melanoma(
70594002)│├Balloon cell melanoma(
39274007)│├Blue nevus, malignant(
67159000)│├Clear cell sarcoma(
271944004)│├Desmoplastic melanoma, malignant(
51757004)│├Epithelioid cell melanoma(
37138001)│├Malignant melanoma in Hutchinson's melanotic freckle(
44474009)│├Malignant melanoma in giant pigmented nevus(
75931002)│├Malignant melanoma in junctional nevus(
915007)│├Malignant melanoma in precancerous melanosis(
18450009)│├Malignant melanoma with B-Raf proto-oncogene, serine/threonine kinase V600E mutation(
830195005)│├Malignant melanoma, metastatic(
372158004)│├Malignant melanoma, no International Classification of Diseases for Oncology subtype(
2092003)│├Malignant melanoma, regressing(
39896009)│├Meningeal melanoma(
726420002)│├Meningeal melanomatosis(
128731008)│├Mixed epithelioid and spindle cell melanoma(
50813003)│├Mucosal lentiginous melanoma(
128732001)│├Nodular melanoma(
2142002)│├Spindle cell melanoma(
68827007)│├Spindle cell melanoma, type A(
24653009)│├Spindle cell melanoma, type B(
40244008)│└Superficial spreading melanoma(
55320002)├Malignant meningeal neoplasm(
414647009)├Malignant neoplasm, primary(
86049000)│├Acinar cell carcinoma(
45410002)│├Acinar cell cystadenocarcinoma(
128703004)│├Acral lentiginous melanoma, malignant(
16974005)│├Adamantinoma of long bones(
56763007)│├Adenoid basal carcinoma(
128637002)│├Adenomyoepithelioma with carcinoma(
703644009)│├Adenosarcoma(
31470003)│├Alveolar rhabdomyosarcoma(
63449009)│├Alveolar soft part sarcoma(
88195001)│├Amelanotic melanoma(
70594002)│├Ameloblastic fibrosarcoma(
27092008)│├Ameloblastic odontosarcoma(
20380000)│├Ameloblastoma, malignant(
88253001)│├Androblastoma, malignant(
12323008)│├Angiomyoliposarcoma(
110457005)│├Angiomyosarcoma(
28953002)│├Askin tumor(
128783001)│├Atypical medullary carcinoma(
128698005)│├Atypical teratoid/rhabdoid tumor(
128792003)│├Balloon cell melanoma(
39274007)│├Basal cell carcinoma(
1338007)│├Basal cell carcinoma, fibroepithelial(
43369006)│├Basal cell carcinoma, nodular(
128636006)│├Basaloid carcinoma(
5843004)│├Basosquamous carcinoma(
37304002)│├Blue nevus, malignant(
67159000)│├Brenner tumor, malignant(
42194009)│├Burkitt lymphoma/leukemia(
397400006)│├Carcinofibroma(
128751007)│├Carcinoma ex pleomorphic adenoma(
17264009)│├Carcinoma showing thymus-like element(
128720000)│├Carcinoma with osteoclast-like giant cells(
128631001)│├Carcinoma with pleomorphic, sarcomatoid or sarcomatous elements(
384950003)│├Carcinoma, anaplastic(
58248003)│├Carcinoma, no subtype(
68453008)│├Carcinoma, undifferentiated(
38549000)│├Carcinosarcoma, embryonal(
112685006)│├Central osteosarcoma(
128770002)│├Chief cell adenocarcinoma(
10146008)│├Chondroblastic osteosarcoma(
76312009)│├Chondroblastoma, malignant(
74279005)│├Chondroid chordoma(
128784007)│├Chondrosarcoma, no International Classification of Diseases for Oncology subtype(
14990007)│├Chordoma(
50007008)│├Choriocarcinoma combined with other germ cell elements(
8734000)│├Chronic myelomonocytic leukemia(
128831004)│├Chronic myeloproliferative disease, no International Classification of Diseases for Oncology subtype(
128842008)│├Clear cell chondrosarcoma(
128775007)│├Clear cell sarcoma (except of Kidney M-89643)(
12622007)│├Clear cell sarcoma of kidney(
24007003)│├Cloacogenic carcinoma(
84570003)│├Combined small cell carcinoma(
21326004)│├Comedocarcinoma, no International Classification of Diseases for Oncology subtype(
722237009)│├Composite Hodgkin and non-Hodgkin lymphoma(
128798004)│├Dedifferentiated chondrosarcoma(
128776008)│├Dedifferentiated chordoma(
128785008)│├Dedifferentiated liposarcoma(
67280001)│├Dermatofibrosarcoma(
76594008)│├Desmoplastic melanoma, malignant(
51757004)│├Desmoplastic small round cell tumor(
128735004)│├Diffuse embryoma(
399560003)│├Duct carcinoma, desmoplastic type(
128699002)│├Dysgerminoma(
60718004)│├Eccrine adenocarcinoma(
128686000)│├Eccrine papillary adenocarcinoma(
128898008)│├Eccrine poroma, malignant(
128685001)│├Embryonal rhabdomyosarcoma(
14269005)│├Embryonal sarcoma(
59583009)│├Encapsulated papillary carcinoma with invasion(
703547006)│├Endometrial stromal sarcoma - category(
446578007)│├Epithelial-myoepithelial carcinoma(
9618003)│├Epithelioid cell melanoma(
37138001)│├Epithelioid leiomyosarcoma(
42392001)│├Epithelioid sarcoma(
59238007)│├Epithelioma, malignant(
71298006)│├Essential thrombocythemia(
128844009)│├Esthesioneurocytoma(
46710009)│├Ewing sarcoma / peripheral neuroectodermal tumor(
703707001)│├Extra-adrenal paraganglioma, malignant(
32512003)│├Fascial fibrosarcoma(
19134004)│├Fibroblastic liposarcoma(
128883006)│├Fibroblastic osteosarcoma(
12690005)│├Fibrosarcoma(
53654007)│├Fibrous histiocytoma, malignant(
34360000)│├Follicular dendritic cell sarcoma(
128816008)│├Ganglioglioma, anaplastic(
128912009)│├Ganglioneuroblastoma(
69515008)││├Intermixed ganglioneuroblastoma(
822951003)││└Nodular ganglioneuroblastoma(
822950002)│├Gastrointestinal stromal sarcoma(
128756002)│├Germ cell tumor, nonseminomatous(
128766005)│├Giant cell sarcoma (except of Bone, M-92503)(
87992000)│├Giant cell tumor of bone, malignant(
10069009)│├Glassy cell carcinoma(
128630000)│├Glomangiosarcoma(
13875003)│├Glomus tumor, malignant(
128908003)│├Granular cell tumor, malignant(
13238004)│├Granulosa cell tumor, malignant(
18861007)│├Hepatoblastoma(
45024009)│├Hepatoid adenocarcinoma(
128706007)│├High grade serous carcinoma(
703563003)│├High grade surface osteosarcoma(
128773000)│├Histiocytic sarcoma(
128813000)│├Hodgkin lymphoma, no International Classification of Diseases for Oncology subtype(
14537002)│├Hypereosinophilic syndrome/chronic eosinophilic leukemia(
128835008)│├Infantile fibrosarcoma(
52040006)│├Infiltrating basal cell carcinoma(
56665009)│├Infiltrating carcinoma with ductal and lobular features(
444057000)│├Infiltrating duct and lobular carcinoma(
35232005)│├Infiltrating duct carcinoma(
82711006)│├Infiltrating duct mixed with other types of carcinoma(
128700001)│├Infiltrating ductular carcinoma(
58477004)│├Infiltrating lobular mixed with other types of carcinoma(
128701002)│├Interdigitating dendritic cell sarcoma(
128815007)│├Intracortical osteosarcoma(
128774006)│├Intraductal papillary adenocarcinoma with invasion(
64524002)│├Intraductal papillary neoplasm with invasive carcinoma(
734075007)│├Intraductal papillary-mucinous carcinoma, invasive(
128692006)│├Intraosseous well differentiated osteosarcoma(
128771003)│├Invasive micropapillary carcinoma of breast(
703578005)│├Juvenile carcinoma of the breast(
41919003)│├Juxtacortical chondrosarcoma(
26211003)│├Langerhans cell histiocytosis, disseminated(
128812005)│├Langerhans cell sarcoma(
128814006)│├Large cell carcinoma(
22687000)│├Large cell carcinoma with rhabdoid phenotype(
128629005)│├Large cell neuroendocrine carcinoma(
128628002)│├Leiomyosarcoma, no subtype(
51549004)│├Leukemia - category(
128931003)│├Leydig cell tumor, malignant(
77870005)│├Liposarcoma, no International Classification of Diseases for Oncology subtype(
49430005)│├Liposarcoma, well differentiated(
28655007)│├Lobular carcinoma(
89740008)││├Lobular carcinoma in situ with microinvasion(
443757001)││├Pleomorphic lobular carcinoma(
860762000)││└Tubulolobular carcinoma(
703596001)│├Low grade serous carcinoma(
703561001)│├Malignant aortic body tumor(
62512005)│├Malignant blood vessel neoplasm, primary(
400156001)│├Malignant carotid body tumor(
16822006)│├Malignant cystic nephroma(
128759009)│├Malignant eccrine spiradenoma(
128895006)│├Malignant giant cell tumor of soft parts(
48460009)│├Malignant glioma - category(
416500007)│├Malignant histiocytosis(
128920006)│├Malignant immunoproliferative neoplasm(
414646000)││├Heavy chain disease(
6381009)││├Immunoproliferative disease, no International Classification of Diseases for Oncology subtype(
86295000)││├Malignant lymphomatoid granulomatosis(
878856000)││├Plasma cell myeloma/plasmacytoma(
399456004)││├Systemic Epstein Barr virus positive T-cell lymphoproliferative disease of childhood(
450906003)││└Waldenstrom's macroglobulinemia(
35562000)│├Malignant lymphoma, no International Classification of Diseases for Oncology subtype(
21964009)│├Malignant mast cell neoplasm(
397010005)││├Malignant mastocytosis(
50150000)││├Mast cell leukemia(
128924002)││└Mast cell sarcoma(
13583002)│├Malignant melanoma in Hutchinson's melanotic freckle(
44474009)│├Malignant melanoma in giant pigmented nevus(
75931002)│├Malignant melanoma in junctional nevus(
915007)│├Malignant melanoma in precancerous melanosis(
18450009)│├Malignant melanoma, no International Classification of Diseases for Oncology subtype(
2092003)│├Malignant melanoma, regressing(
39896009)│├Malignant mixed tumor, carcinomatous type(
40459000)│├Malignant mixed tumor, chondrosarcomatous type(
82993000)│├Malignant mixed tumor, osteosarcomatous type(
4392007)│├Malignant neuroendocrine neoplasm, epithelial(
127575007)│├Malignant neuroendocrine neoplasm, neural(
127576008)││├Composite paraganglioma(
817953005)││├Composite pheochromocytoma(
817952000)││├Esthesioneuroblastoma(
76060004)││├Esthesioneuroepithelioma(
68614005)││├Malignant pheochromocytoma(
29370006)││├Medulloblastoma - category(
443334005)││├Neuroblastoma(
87364003)││├Paraganglioma, malignant(
9903002)││├Pineoblastoma(
31671006)││├Primitive neuroectodermal tumor(
39781001)││├Retinoblastoma(
19906005)││├Retinoblastoma, differentiated(
26019009)││├Retinoblastoma, diffuse(
128793008)││└Retinoblastoma, undifferentiated(
12354007)│├Malignant peripheral nerve sheath tumor(
19897006)│├Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation(
354002)│├Malignant phyllodes tumor(
87913009)│├Malignant pituitary blastoma(
789437003)│├Malignant rhabdoid tumor(
83118000)│├Malignant squamous tumor, primary(
252988009)││├Adenoid squamous cell carcinoma(
85956000)││├Basaloid squamous cell carcinoma(
128634009)││├Lymphoepithelial carcinoma(
7300000)││├Papillary carcinoma(
25910003)││├Papillary squamous cell carcinoma(
39056008)││├Pseudovascular squamous cell carcinoma(
733897002)││├Squamous cell carcinoma with horn formation(
128633003)││├Squamous cell carcinoma, clear cell type(
128635005)││├Squamous cell carcinoma, keratinizing(
18048008)││├Squamous cell carcinoma, large cell, nonkeratinizing(
45490001)││├Squamous cell carcinoma, microinvasive(
12478003)││├Squamous cell carcinoma, no International Classification of Diseases for Oncology subtype(
28899001)│││├Human papillomavirus negative squamous cell carcinoma(
783213006)│││├Human papillomavirus positive squamous cell carcinoma(
783212001)│││├Metaplastic squamous cell carcinoma(
399739006)│││└Squamous cell carcinoma in post-traumatic skin lesion(
399494004)││├Squamous cell carcinoma, small cell, nonkeratinizing(
35718007)││├Squamous cell carcinoma, spindle cell(
10288008)││└Verrucous carcinoma(
89906000)│├Malignant tenosynovial giant cell tumor(
128778009)│├Malignant teratoma, trophoblastic(
65646006)│├Malignant tumor, clear cell type(
128627007)│├Malignant tumor, fusiform cell type(
88897007)│├Malignant tumor, giant cell type(
83950009)│├Malignant tumor, small cell type(
82267002)│├Mammary analogue secretory carcinoma(
734058001)│├Medullary carcinoma with lymphoid stroma(
85654004)│├Meningeal melanoma(
726420002)│├Meningeal melanomatosis(
128731008)│├Meningeal sarcomatosis(
14494009)│├Meningioma, malignant(
78303004)│├Mesenchymal chondrosarcoma(
56565002)│├Mesenchymoma, malignant(
89623007)│├Mesonephroma, malignant(
2221008)│├Mesothelioma, malignant(
62064005)│├Metaplastic carcinoma(
128705006)││├Fibromatosis-like metaplastic carcinoma(
733875004)││└Metaplastic squamous cell carcinoma(
399739006)│├Metaplastic thymoma(
726421003)│├Metatypical carcinoma(
6641007)│├Mixed acinar-ductal carcinoma(
450897002)│├Mixed epithelioid and spindle cell melanoma(
50813003)│├Mixed germ cell tumor(
32844007)│├Mixed liposarcoma(
11073003)│├Mixed tumor, malignant(
8145008)│├Mixed type rhabdomyosarcoma(
62383007)│├Mucin-producing adenocarcinoma(
900006)│├Mucinous cystic neoplasm with invasive carcinoma(
734074006)│├Mucosal lentiginous melanoma(
128732001)│├Mullerian mixed tumor(
84427001)│├Multifocal superficial basal cell carcinoma(
61098004)│├Myelodysplastic syndrome with 5q- syndrome(
128837000)│├Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia(
789435006)│├Myelodysplastic syndrome, no International Classification of Diseases for Oncology subtype(
373381004)│├Myeloliposarcoma(
75940003)│├Myelosclerosis with myeloid metaplasia(
128843003)│├Myofibroblastic sarcoma(
789434005)││└Low grade myofibroblastic sarcoma(
703615007)│├Myosarcoma(
20667008)│├Myxoid chondrosarcoma(
75622000)│├Myxoid leiomyosarcoma(
16090008)│├Myxoid liposarcoma(
27849002)│├Myxosarcoma(
28351005)│├Nephroblastoma(
25081006)│├Neuroepithelioma(
55045006)│├Nodular hidradenoma, malignant(
128894005)│├Nodular melanoma(
2142002)│├Non-Hodgkin lymphoma - category(
128929007)│├Non-small cell carcinoma(
128632008)│├Nonencapsulated sclerosing carcinoma(
62681000)│├Odontogenic carcinosarcoma(
128780003)│├Odontogenic tumor, malignant(
26888009)││├Clear cell odontogenic carcinoma(
734032001)││├Intraosseous mucoepidermoid carcinoma(
699229009)││├Malignant odontogenic ghost cell tumor(
110458000)│││└Odontogenic ghost cell carcinoma(
788580003)││├Primary ameloblastic carcinoma(
733414001)││├Primary intra-osseous carcinoma(
278411006)││├Secondary dedifferentiated intraosseous ameloblastic carcinoma(
734064008)││└Secondary dedifferentiated peripheral ameloblastic carcinoma(
734063002)│├Olfactory neurogenic tumor(
53968002)│├Ossifying fibromyxoid tumor, malignant(
703631004)│├Osteosarcoma, no International Classification of Diseases for Oncology subtype(
21708004)│├Paget's disease and infiltrating duct carcinoma of breast(
82591005)│├Paget's disease and intraductal carcinoma of breast(
54666007)│├Paget's disease of skin(
232336001)│├Pancreatoblastoma(
53618008)│├Papillary meningioma(
128840000)│├Papillary transitional cell carcinoma(
12400006)│├Parosteal osteosarcoma(
128918008)│├Periosteal fibrosarcoma(
65140001)│├Periosteal osteosarcoma(
128772005)│├Perivascular epithelioid tumor, malignant(
703605001)│├Pilomatrix carcinoma(
24762001)│├Pleomorphic liposarcoma(
112683004)│├Pleomorphic rhabdomyosarcoma(
77455004)│├Pleuropulmonary blastoma(
128763002)│├Polycythemia vera(
128841001)│├Polyembryoma(
28325008)│├Polygonal cell carcinoma(
70401000)│├Polymorphous low grade adenocarcinoma(
128702009)│├Poorly differentiated carcinoma(
703078002)│├Precursor B-lymphoblastic leukemia/lymphoblastic lymphoma(
397347001)│├Precursor T cell lymphoblastic leukemia/lymphoblastic lymphoma(
397348006)│├Primary malignant adenomatous neoplasm(
450594004)││├Acidophil carcinoma(
51217003)││├Adenocarcinoid tumor(
86293007)││├Adenocarcinoma in adenomatous polyp(
43233001)││├Adenocarcinoma in adenomatous polyposis coli(
57513006)││├Adenocarcinoma in multiple adenomatous polyps(
47299001)││├Adenocarcinoma in tubulovillous adenoma(
5658009)││├Adenocarcinoma in villous adenoma(
36087009)││├Adenocarcinoma of anal glands(
128655006)││├Adenocarcinoma with apocrine metaplasia(
22694002)││├Adenocarcinoma with cartilaginous and osseous metaplasia(
56484001)││├Adenocarcinoma with metaplasia(
253026002)││├Adenocarcinoma with mixed subtypes(
128662002)││├Adenocarcinoma with neuroendocrine differentiation(
128704005)││├Adenocarcinoma with spindle cell metaplasia(
68358000)││├Adenocarcinoma with squamous metaplasia(
15176003)││├Adenocarcinoma, endocervical type(
128682003)││├Adenocarcinoma, intestinal type(
25190001)││├Adenocarcinoma, no subtype(
35917007)││├Adenosquamous carcinoma(
59367005)││├Adrenal cortical carcinoma(
2227007)││├Alveolar adenocarcinoma(
36310008)││├Apocrine adenocarcinoma(
57141000)││├Basal cell adenocarcinoma(
34603009)││├Basophil carcinoma(
47107000)││├Bile duct cystadenocarcinoma(
50422007)││├Bronchiolo-alveolar adenocarcinoma(
112677002)││├Bronchiolo-alveolar carcinoma, mixed mucinous and non-mucinous(
128661009)││├Bronchiolo-alveolar carcinoma, mucinous(
128660005)││├Bronchiolo-alveolar carcinoma, non-mucinous(
128659000)││├Carcinoma of salivary gland type(
384951004)│││├Adenoid cystic carcinoma(
11671000)│││├Malignant myoepithelioma(
128884000)│││└Mucoepidermoid carcinoma(
4079000)│││ ├Intraosseous mucoepidermoid carcinoma(
699229009)│││ ├Mucoepidermoid carcinoma, high grade(
397081004)│││ ├Mucoepidermoid carcinoma, intermediate grade(
397080003)│││ ├Mucoepidermoid carcinoma, low grade(
397079001)│││ ├Mucoepidermoid eccrine carcinoma(
400180002)│││ └Sclerosing mucoepidermoid carcinoma with eosinophilia(
822964002)││├Carcinoma simplex(
45881000)││├Carcinoma, diffuse type(
24505004)││├Ceruminous adenocarcinoma(
58069009)││├Cholangiocarcinoma(
70179006)││├Chromophobe carcinoma(
1443001)││├Clear cell adenocarcinofibroma(
128891002)││├Clear cell adenocarcinoma(
30546008)││├Collecting duct carcinoma(
128669006)││├Combined hepatocellular carcinoma and cholangiocarcinoma(
52178006)││├Composite carcinoid(
51465000)││├Cribriform carcinoma(
30156004)││├Cribriform comedo-type adenocarcinoma(
733838009)││├Cyst-associated renal cell carcinoma(
128666004)││├Cystadenocarcinoma(
21008007)││├Endometrioid adenocarcinoma, ciliated cell variant(
128681005)││├Endometrioid adenocarcinoma, secretory variant(
128680006)││├Endometrioid adenofibroma, malignant(
18105004)││├Endometrioid carcinoma(
30289006)││├Fetal adenocarcinoma(
128893004)││├Follicular adenocarcinoma(
5257006)││├Follicular adenocarcinoma, trabecular(
72174007)││├Follicular adenocarcinoma, well differentiated(
28173006)││├Follicular carcinoma, minimally invasive(
128671006)││├Gastrinoma, malignant(
19756007)││├Glucagonoma, malignant(
66515009)││├Glycogen-rich carcinoma(
74280008)││├Granular cell carcinoma(
69028005)││├Hepatocellular carcinoma(
25370001)││├Hepatocellular carcinoma, clear cell type(
128649001)││├Hepatocellular carcinoma, pleomorphic type(
128650001)││├Hepatocellular carcinoma, scirrhous(
128646008)││├Hepatocellular carcinoma, spindle cell variant(
128648009)││├Insular carcinoma(
128673009)││├Insulinoma, malignant(
20955008)││├Klatskin's tumor(
6492006)││├Linitis plastica(
37995004)││├Lipid-rich carcinoma(
3839000)││├Medullary carcinoma with amyloid stroma(
128916007)││├Meibomian adenocarcinoma(
103692002)││├Micropapillary adenocarcinoma(
733878002)││├Micropapillary carcinoma(
450895005)││├Mixed acidophil-basophil carcinoma(
23444003)││├Mixed cell adenocarcinoma(
38958001)││├Mixed islet cell and exocrine adenocarcinoma(
999000)││├Mixed medullary-follicular carcinoma(
128678000)││├Mixed medullary-papillary carcinoma(
128679008)││├Mucinous adenocarcinofibroma(
128888002)││├Mucinous adenocarcinoma(
72495009)││├Mucinous minimally invasive adenocarcinoma(
733884004)││├Mucinous tubular and spindle cell carcinoma(
734077004)││├Multilocular cystic renal cell neoplasm of low malignant potential(
734036003)││├Non-intestinal type adenocarcinoma(
732977002)││├Non-mucinous minimally invasive adenocarcinoma(
733885003)││├Oxyphilic adenocarcinoma(
57596004)││├Pancreatobiliary-type carcinoma(
450894009)││├Papillary adenocarcinoma(
4797003)││├Papillary carcinoma, columnar cell(
128677005)││├Papillary carcinoma, follicular variant(
21968007)││├Papillary carcinoma, oxyphilic cell(
128675002)││├Papillary microcarcinoma(
128674003)││├Parietal cell carcinoma(
128654005)││├Pituitary carcinoma(
128665000)││├Renal cell carcinoma(
41607009)││├Renal cell carcinoma, chromophobe cell(
128667008)││├Renal cell carcinoma, sarcomatoid(
128668003)││├Scirrhous adenocarcinoma(
4584002)││├Sebaceous adenocarcinoma(
54734006)││├Sebaceous lymphadenocarcinoma(
734055003)││├Serous adenocarcinofibroma(
128886003)││├Serrated adenocarcinoma(
450948005)││├Solid carcinoma(
81920005)││├Somatostatinoma, malignant(
128643000)││├Superficial spreading adenocarcinoma(
81446001)││├Sweat gland adenocarcinoma(
32272007)│││└Endocrine mucin-producing sweat gland carcinoma(
822967009)││├Thymic carcinoma with adenoid cystic carcinoma-like features(
725504002)││├Trabecular adenocarcinoma(
29792007)││├Tubular adenocarcinoma(
4631006)││├Villous adenocarcinoma(
28558000)││├Vipoma, malignant(
31131002)││└Water-clear cell adenocarcinoma(
80727009)│├Primary sarcoma(
719952009)│├Primary seminoma(
720346009)│├Pseudosarcomatous carcinoma(
23109009)│├Refractory anemia(
128845005)│├Refractory anemia with excess blasts(
128847002)│├Refractory anemia with excess blasts in transformation(
128848007)│├Refractory anemia with sideroblasts(
128846006)│├Refractory cytopenia with multilineage dysplasia(
128836009)│├Regressed germ cell tumor(
399523002)│├Rhabdomyosarcoma with ganglionic differentiation(
128750008)│├Rhabdomyosarcoma, no subtype(
30924005)│├Sarcoma, no International Classification of Diseases for Oncology subtype(
2424003)│├Schneiderian carcinoma(
5600009)│├Sclerosing sweat duct carcinoma(
128896007)│├Secondary osteosarcoma(
703692009)│├Seromucinous carcinoma(
703568007)│├Serous carcinoma(
90725004)│├Sertoli cell carcinoma(
80091008)│├Sertoli-Leydig cell tumor, poorly differentiated(
128906004)│├Sertoli-Leydig cell tumor, poorly differentiated, with heterologous elements(
128727002)│├Signet ring cell carcinoma(
87737001)│├Skin appendage carcinoma(
64000002)│├Small cell carcinoma(
74364000)│├Small cell carcinoma, fusiform cell(
74042001)│├Small cell carcinoma, intermediate cell(
5958006)│├Small cell osteosarcoma(
12302002)│├Small cell sarcoma(
73506006)│├Solid papillary carcinoma with invasion(
703594003)│├Solid pseudopapillary carcinoma(
116061001)│├Solitary fibrous tumor, malignant(
128737007)│├Spermatocytic seminoma(
9294008)│├Spindle cell melanoma(
68827007)│├Spindle cell melanoma, type A(
24653009)│├Spindle cell melanoma, type B(
40244008)│├Spindle cell rhabdomyosarcoma(
128749008)│├Spindle cell sarcoma(
9801004)││└Biphenotypic sinonasal sarcoma(
789405004)│├Spindle epithelial tumor with thymus-like element(
128719006)│├Spongioneuroblastoma(
64059005)│├Steroid cell tumor, malignant(
128907008)│├Stromal sarcoma(
128753005)│├Struma ovarii, malignant(
18854008)│├Superficial spreading melanoma(
55320002)│├Synovial sarcoma - category(
425535000)│├Telangiectatic osteosarcoma(
78453009)│├Teratoid medulloepithelioma(
88591002)│├Thecoma, malignant(
57622002)│├Therapy-related myelodysplastic syndrome(
128838005)│├Thymoma, malignant(
15949004)│├Thymoma, type A, malignant(
128708008)│├Thymoma, type AB, malignant(
128710005)│├Thymoma, type B1, malignant(
128712002)│├Thymoma, type B2, malignant(
128714001)│├Thymoma, type B3, malignant(
128716004)│├Thymoma, type C(
128717008)│├Transitional cell carcinoma(
27090000)│├Transitional cell carcinoma, micropapillary(
128639004)│├Transitional cell carcinoma, spindle cell(
112676006)│├Trichilemmocarcinoma(
128624000)│├Trophoblastic tumor, epithelioid(
128767001)│├Tumor cells, malignant(
88400008)│└Undifferentiated sarcoma(
128734000)├Malignant nerve sheath tumor - category(
400121000)├Malignant skin appendage tumor(
314921004)│├Malignant neoplasm with apocrine differentiation(
400187004)││├Apocrine adenocarcinoma(
57141000)││├Ceruminous adenocarcinoma(
58069009)││├Paget's disease of skin(
232336001)││└Syringocystadenocarcinoma papilliferum(
822966000)│├Malignant neoplasm with eccrine differentiation(
400172009)││├Adenoid cystic eccrine carcinoma(
399968001)││├Basal cell carcinoma with eccrine differentiation(
399470004)││├Eccrine adenocarcinoma(
128686000)││├Eccrine papillary adenocarcinoma(
128898008)││├Eccrine poroma, malignant(
128685001)││├Malignant chondroid syringoma(
400124008)││├Malignant cylindroma of skin(
399941001)││├Malignant eccrine spiradenoma(
128895006)││├Mucinous eccrine carcinoma(
399540006)││├Mucoepidermoid eccrine carcinoma(
400180002)││├Nodular hidradenoma, malignant(
128894005)││├Sclerosing sweat duct carcinoma(
128896007)││├Small cell eccrine carcinoma(
400134004)││└Sweat gland adenocarcinoma(
32272007)││ └Endocrine mucin-producing sweat gland carcinoma(
822967009)│├Malignant neoplasm with pilar differentiation(
399878004)│├Sebaceous adenocarcinoma(
54734006)│└Skin appendage carcinoma(
64000002)├Malignant stromal tumor(
253048008)├Neoplasm, malignant, uncertain whether primary or metastatic(
6219000)├Neoplasm, metastatic(
14799000)│├Adenocarcinoma, metastatic(
4590003)│├Carcinoma, metastatic(
79282002)││├Metastatic renal cell carcinoma(
838281000)││└Metastatic small cell carcinoma(
709194001)│├Carcinomatosis(
7010000)│├Choriocarcinoma, metastatic(
370079006)│├Kaposi's sarcoma, metastatic(
372149006)│├Leukemic infiltration(
446688004)│├Malignant blood vessel neoplasm, metastatic(
423251006)│├Malignant lymphoma, metastatic(
110459008)│├Malignant melanoma, metastatic(
372158004)│├Metastatic Mullerian mixed tumor(
708974000)│├Metastatic hepatocellular carcinoma(
708973006)│├Metastatic leiomyosarcoma(
709190005)│├Metastatic signet ring cell carcinoma(
4305004)│├Metastatic teratoma(
709195000)│├Metastatic thymic carcinoma(
709196004)│├Neuroblastoma, metastatic(
704147007)│├Papillary adenocarcinoma, metastatic(
708939001)│├Pseudomyxoma peritonei(
112679004)│├Sarcoma, metastatic(
372152003)│├Seminoma, metastatic(
708937004)│└Squamous cell carcinoma, metastatic(
64204000)├Sarcoma - category(
372151005)│├Adenosarcoma(
31470003)│├Alveolar soft part sarcoma(
88195001)│├Ameloblastic fibrosarcoma(
27092008)│├Ameloblastic odontosarcoma(
20380000)│├Angiomyoliposarcoma(
110457005)│├Angiosarcoma(
863926008)││├Hemangiosarcoma(
39000009)││└Lymphangiosarcoma(
63373002)│├Central osteosarcoma(
128770002)│├Cerebellar sarcoma(
17302008)│├Chondroblastic osteosarcoma(
76312009)│├Chondrosarcoma - category(
443489009)│├Clear cell sarcoma(
271944004)│├Clear cell sarcoma of kidney(
24007003)│├Dedifferentiated liposarcoma(
67280001)│├Desmoplastic small round cell tumor(
128735004)│├Embryonal sarcoma(
59583009)│├Endometrial stromal sarcoma - category(
446578007)│├Epithelioid sarcoma(
59238007)│├Ewing's sarcoma(
76909002)│├Fascial fibrosarcoma(
19134004)│├Fibroblastic liposarcoma(
128883006)│├Fibroblastic osteosarcoma(
12690005)│├Fibrosarcoma(
53654007)│├Follicular dendritic cell sarcoma(
128816008)│├Gastrointestinal stromal sarcoma(
128756002)│├Giant cell sarcoma (except of Bone, M-92503)(
87992000)│├Gliosarcoma(
35262004)│├Glomangiosarcoma(
13875003)│├High grade surface osteosarcoma(
128773000)│├Histiocytic sarcoma(
128813000)│├Infantile fibrosarcoma(
52040006)│├Interdigitating dendritic cell sarcoma(
128815007)│├Intracortical osteosarcoma(
128774006)│├Intraosseous well differentiated osteosarcoma(
128771003)│├Kaposi's sarcoma, morphology(
49937004)│├Kupffer cell sarcoma(
69317001)│├Langerhans cell sarcoma(
128814006)│├Liposarcoma, no International Classification of Diseases for Oncology subtype(
49430005)│├Liposarcoma, well differentiated(
28655007)│├Malignant myomatous tumor(
253046007)│├Mast cell sarcoma(
13583002)│├Meningeal sarcomatosis(
14494009)│├Mixed liposarcoma(
11073003)│├Myofibroblastic sarcoma(
789434005)││└Low grade myofibroblastic sarcoma(
703615007)│├Myxofibrosarcoma(
703609007)│├Myxoid liposarcoma(
27849002)│├Myxosarcoma(
28351005)│├Osteosarcoma, no International Classification of Diseases for Oncology subtype(
21708004)│├Parosteal osteosarcoma(
128918008)│├Periosteal fibrosarcoma(
65140001)│├Periosteal osteosarcoma(
128772005)│├Pleomorphic liposarcoma(
112683004)│├Primary sarcoma(
719952009)│├Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation(
734072005)│├Sarcoma, metastatic(
372152003)│├Sarcoma, no International Classification of Diseases for Oncology subtype(
2424003)│├Sarcomatosis(
9395006)│├Secondary osteosarcoma(
703692009)│├Small cell osteosarcoma(
12302002)│├Small cell sarcoma(
73506006)│├Spindle cell sarcoma(
9801004)││└Biphenotypic sinonasal sarcoma(
789405004)│├Stromal sarcoma(
128753005)│├Synovial sarcoma - category(
425535000)│├Telangiectatic osteosarcoma(
78453009)│└Undifferentiated sarcoma(
128734000)â””Squamous cell carcinoma - category(
400155002) ├Adenosquamous carcinoma(
59367005) ├Malignant squamous tumor, primary(
252988009) │├Adenoid squamous cell carcinoma(
85956000) │├Basaloid squamous cell carcinoma(
128634009) │├Lymphoepithelial carcinoma(
7300000) │├Papillary carcinoma(
25910003) │├Papillary squamous cell carcinoma(
39056008) │├Pseudovascular squamous cell carcinoma(
733897002) │├Squamous cell carcinoma with horn formation(
128633003) │├Squamous cell carcinoma, clear cell type(
128635005) │├Squamous cell carcinoma, keratinizing(
18048008) │├Squamous cell carcinoma, large cell, nonkeratinizing(
45490001) │├Squamous cell carcinoma, microinvasive(
12478003) │├Squamous cell carcinoma, no International Classification of Diseases for Oncology subtype(
28899001) ││├Human papillomavirus negative squamous cell carcinoma(
783213006) ││├Human papillomavirus positive squamous cell carcinoma(
783212001) ││├Metaplastic squamous cell carcinoma(
399739006) ││└Squamous cell carcinoma in post-traumatic skin lesion(
399494004) │├Squamous cell carcinoma, small cell, nonkeratinizing(
35718007) │├Squamous cell carcinoma, spindle cell(
10288008) │└Verrucous carcinoma(
89906000) â””Squamous cell carcinoma, metastatic(
64204000)[Inactive] Morphologic Abnormality
Carcinoma resembling breast carcinoma(
399666000)Ductal carcinoma in situ with microinvasion and involving nipple skin(
444134008)Malignant cystosarcoma phyllodes(
189826001)Malignant lymphangioma(
253056006)Papillary carcinoma, encapsulated(
128676001)Papillary serous cystadenocarcinoma(
90282004)Primitive polar spongioblastoma(
189919000)Serous surface papillary carcinoma(
15674004)Signet ring carcinoma, primary cutaneous(
399887008)